Clinical Trials Directory

Trials / Completed

CompletedNCT02268981

Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Schön Klinik Berchtesgadener Land · Academic / Other
Sex
All
Age
30 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study will investigate the effects of a reservoir nasal cannula (Oxymizer®) compared to a conventional nasal cannula (CNC) in patients with idiopathic pulmonary fibrosis.

Detailed description

Patients will be recruited during a 3-week inpatient pulmonary rehabilitation program. They will perform the following three interventions on consecutive days and will repeat them after a week. During these days the time table for prescribed physical activities and therapies will be kept in a comparable fashion. The following 3 interventions will be performed in randomized order: Day A: The Patient wears a conventional nasal cannula for 12 h with oxygen flow rate as prescribed during ADL Day B: The Patient wears the Oxymizer® with prescribed oxygen flow rate for 12 h during ADL Day C: The patient wears the Oxymizer® with a flow rate reduced by 1l/min in comparison to the prescribed oxygen flow rate, for 12h The following week the same measurements will be repeated. The mean of the corresponding two measures will be calculated for each approach.

Conditions

Interventions

TypeNameDescription
DEVICEOxymizer® compared to CNCOxygen Saturation measurement for 12 h with CNC
DEVICEOxymizer® compared to CNCOxygen Saturation measurement for 12 h with Oxymizer®
DEVICEOxymizer® compared to CNCSaturation measurement for 12 h with Oxymizer® by reduced flow rate (-1l/min)

Timeline

Start date
2014-09-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2014-10-20
Last updated
2015-09-03

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02268981. Inclusion in this directory is not an endorsement.